Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-08

Clinical Trial Update: Comparison Between Darbapoeitin Alpha and Roxadustat in CKD-related Anemia

View source ↗

Summary

A completed clinical trial comparing darbepoetin alfa versus roxadustat in chronic kidney disease–related anemia, including stable dialysis patients, to assess …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARANESP (DARBEPOETIN ALFA)
  • Roxadustat (roxadustat)

Snippet

Sponsor: Ain Shams University | Conditions: CKD Anemia, CKD Anemia in Stable Dialysis Patients | Status: COMPLETED